← All candidates
No insider filings on record.
19 filings on record.
NERVMinerva Neurosciences, Inc.
NasdaqCM · Healthcare · $198.15M
$4.15
-0.24% · Sep 11
No insider filings on record.
Minerva Neurosciences, Inc. hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 3 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what NERV ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$198.15M
Float
34.3M
72% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
No insider transactions on file for NERV yet.
Context
Wall St
$10.33 avg target
+149.0% vs today · 3 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$0.17 act−$0.16
Q1 '26−$0.17 act−$0.04
Q4 '25−$0.64 act−$0.53
Q3 '25−$0.36 act
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice